Group 1 - The stock price of Suochen Technology (688507.SH) fell by 5.05% to 76.69 yuan as of the close on May 15, 2023, indicating that the stock is currently in a state of decline since its IPO [1] - Suochen Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on April 18, 2023, with an issuance of 10.33 million shares at a price of 245.56 yuan per share, resulting in a total fundraising amount of approximately 253.75 million yuan [1] - The net fundraising amount was 231.57 million yuan, exceeding the original plan by 134.68 million yuan, with the funds allocated for various projects including R&D center construction and marketing network development [1] Group 2 - On June 13, 2023, Suochen Technology announced a profit distribution plan, distributing a cash dividend of 0.15 yuan per share and a capital increase of 0.48 shares for every share held, resulting in a total of 6.20 million yuan in cash dividends and 19.84 million shares being transferred [2] - The total share capital after the distribution will be 61.17 million shares, with the ex-dividend date set for June 20, 2023 [2] - For the 2023 annual profit distribution, approved on June 12, 2024, the company plans to distribute a cash dividend of 3.80 yuan for every 10 shares and a capital increase of 4.60 shares for every 10 shares held, with the ex-dividend date set for June 19, 2024 [2]

Group 1 - The core point of the news is that Suzhou Blue Three Venture Capital Co., Ltd. plans to reduce its holdings in Jiangsu Boyun by up to 971,333 shares, which represents 0.98% of the total share capital [1] - Jiangsu Boyun's shareholding structure will not be significantly affected by this reduction, as Blue Three Venture Capital is not a controlling shareholder or actual controller [1] - Jiangsu Boyun's stock is currently in a state of decline since its IPO on June 1, 2021, with an initial offering price of 55.88 yuan per share [2] Group 2 - Jiangsu Boyun raised a total of 814 million yuan from its initial public offering, with a net amount of 721 million yuan after deducting issuance costs [2] - The company plans to use the raised funds for expanding modified plastics production and establishing a research and testing center [2] - Jiangsu Boyun announced a dividend plan on March 25, 2022, proposing a distribution of 10 yuan per 10 shares and a bonus issue of 7 shares [3]

Group 1 - The core viewpoint of the articles highlights the financial performance and stock market status of Suochen Technology, which is currently facing a decline in stock price since its IPO [1] - Suochen Technology's stock closed at 77.33 yuan, reflecting a drop of 6.27%, with a total market capitalization of 6.891 billion yuan [1] - The company went public on April 18, 2023, with an initial offering price of 245.56 yuan per share, indicating that the stock is currently in a state of decline [1] Group 2 - The company raised a total of 253.75 million yuan through its IPO, with a net amount of 231.57 million yuan, exceeding the original plan by 134.68 million yuan [1] - The funds raised are allocated for various projects, including the construction of a research and development center and the production of underwater noise testing instruments [1] - The underwriting fees for the IPO amounted to 22.17 million yuan, with the main underwriter being Haitong Securities [1] Group 3 - Suochen Technology announced a cash dividend of 0.15 yuan per share and a capital increase of 0.48 shares per share based on a total share capital of 41,333,400 shares [2] - The total cash dividend distributed was 6.20 million yuan, and the capital increase resulted in an additional 19.84 million shares, bringing the total share capital to 61,173,432 shares [2] - For the 2023 annual profit distribution, the company plans to distribute a cash dividend of 3.80 yuan for every 10 shares and a capital increase of 4.60 shares for every 10 shares [2]

Core Viewpoint - Shenzhen Qianhai Shengtai Investment Enterprise plans to reduce its stake in Chengda Pharmaceutical by up to 4,894,943 shares, representing 3.23% of the company's total share capital, due to the shareholder's operational needs [1][2] Group 1: Shareholder Information - Shenzhen Qianhai Shengtai holds 15,901,840 shares, accounting for 10.50% of the company's total share capital after excluding repurchased shares [1][2] - The planned reduction will occur within three months from May 30, 2025, to August 29, 2025, through block trading [1] - The shareholder is not a controlling shareholder or actual controller of the company, and the reduction will not lead to a change in control or significantly impact the company's governance structure [2] Group 2: Company Financials - Chengda Pharmaceutical's initial public offering raised a total of 1.757 billion yuan, with a net amount of 1.621 billion yuan after deducting issuance costs [3] - The company reported a revenue of 333.13 million yuan in 2024, a decrease of 19.59% compared to 2023 [4][5] - The net profit attributable to shareholders was -28.10 million yuan in 2024, a decline of 130.89% year-on-year [4][5] - For Q1 2025, the company achieved a revenue of 76.31 million yuan, down 24.37% year-on-year, with a net loss of -1.40 million yuan [6]

Core Viewpoint - Aojie Technology (688220.SH) is currently facing a decline in stock price, with a drop of 6.64% to 89.48 yuan, indicating a state of being below its initial public offering (IPO) price [1] Financial Performance - In 2024, Aojie Technology reported a revenue of 3.39 billion yuan, representing a year-on-year increase of 30.23% compared to 2.14 billion yuan in 2022 [2][3] - The net profit attributable to shareholders was -693 million yuan in 2024, worsening from -505 million yuan in the previous year [2][3] - The company's net profit excluding non-recurring gains and losses was -707 million yuan in 2024, compared to -658 million yuan in 2023 [2][3] - The net cash flow from operating activities was -404 million yuan in 2024, an improvement from -678 million yuan in 2023 [2][3] IPO and Fundraising - Aojie Technology went public on January 14, 2022, with an IPO price of 164.54 yuan per share, raising a total of 6.883 billion yuan, which was 4.166 billion yuan more than initially planned [1] - The funds raised are intended for projects including new communication chip design and high-precision navigation solutions [1]

Core Viewpoint - Jiangsu Boyun (301003.SZ) announced that shareholder Lu Shiping plans to reduce his holdings in the company due to personal financial needs, which may impact the stock's performance as it is currently in a state of decline since its IPO. Group 1: Shareholder Actions - Lu Shiping intends to reduce his holdings by up to 971,333 shares through centralized bidding and up to 1,942,666 shares through block trading, representing a maximum of 1% and 2% of Jiangsu Boyun's total share capital, respectively, after excluding repurchased shares [1] - Lu Shiping currently holds 21,198,045 shares, accounting for 21.40% of Jiangsu Boyun's total share capital, and is the second-largest shareholder as of December 31, 2024 [1] Group 2: IPO and Financials - Jiangsu Boyun raised a total of 814 million yuan from its initial public offering, with a net amount of 721 million yuan after deducting issuance costs, exceeding the original plan by 261 million yuan [2] - The company initially planned to raise 460 million yuan for projects including the expansion of modified plastics and the establishment of a research and testing center [2] - The total issuance costs amounted to 93.14 million yuan, with underwriting fees of 72.03 million yuan [3] Group 3: Dividend Announcement - On March 25, 2022, Jiangsu Boyun announced a dividend plan, proposing a distribution of 10 yuan per 10 shares (pre-tax) and a bonus issue of 7 shares, with the record date set for March 31, 2022 [3]

Group 1 - Shanghai Bunge plans to reduce its stake in Suobao Protein by up to 5,743,615 shares, representing no more than 3% of the total share capital [1] - The reduction will occur through a combination of centralized bidding and block trading, with a maximum of 1,914,500 shares (1% of total share capital) through centralized bidding and 3,829,115 shares (2% of total share capital) through block trading [1] - As of the announcement date, Shanghai Bunge holds 7,179,715 shares, accounting for 3.75% of the total share capital, all of which were acquired before the company's IPO [1] Group 2 - Suobao Protein was listed on the Shanghai Stock Exchange on December 15, 2023, with an issuance of 47,864,800 shares at a price of 21.29 yuan per share, raising a total of 1,019.04 million yuan [2] - The net proceeds from the offering amounted to 979.46 million yuan, exceeding the original plan by 424.87 million yuan [2] - The funds raised will be allocated to the construction of a 30,000-ton soybean textured protein production line, a 5,000-ton soybean granular protein production line, a 75T medium-temperature and medium-pressure efficient coal powder boiler project, and to supplement working capital [2]

Group 1 - Liu Xiaodong, the Vice General Manager of Guangzhou Fantuo Digital Creative Technology Co., Ltd. (Fantuo Digital, 301313.SZ), exceeded his planned share reduction by 4,068 shares, selling a total of 94,068 shares instead of the planned 90,000 shares [1][2] - The average transaction price for the excess shares sold was 27.65 yuan per share, resulting in a total transaction amount of 112,500 yuan, which accounted for 0.0039% of Fantuo Digital's total share capital [1][2] - The Guangdong Securities Regulatory Bureau issued a warning letter to Liu Xiaodong for violating regulations regarding share reduction management [2] Group 2 - Fantuo Digital was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on September 30, 2022, with an initial public offering of 25,583,400 shares at a price of 25.25 yuan per share [2] - The total amount raised from the initial public offering was 645.98 million yuan, with a net amount of 555.90 million yuan after deducting issuance costs [2] - The company is currently in a state of stock price decline, having reported a projected net loss of 150 million to 200 million yuan for the fiscal year 2024, compared to a profit of 10.50 million yuan in the previous year [3]